Your browser doesn't support javascript.
loading
Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.
Molinos-Quintana, Águeda; Alonso-Saladrigues, Anna; Herrero, Blanca; Caballero-Velázquez, Teresa; Galán-Gómez, Víctor; Panesso, Melissa; Torrebadell, Montserrat; Delgado-Serrano, Javier; Pérez de Soto, Concepción; Faura, Anna; González-Martínez, Berta; Castillo-Robleda, Ana; Diaz-de-Heredia, Cristina; Pérez-Martínez, Antonio; Pérez-Hurtado, José María; Rives, Susana; Pérez-Simón, José Antonio.
Afiliación
  • Molinos-Quintana Á; Pediatric Unit, Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.
  • Alonso-Saladrigues A; CAR T-cell Unit. Leukemia and Lymphoma Department. Pediatric Cancer Center Barcelona (PCCB). Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain.
  • Herrero B; Pediatric Hemato-Oncology Department, Peditric University Hospital del Niño Jesús, Madrid, Spain.
  • Caballero-Velázquez T; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.
  • Galán-Gómez V; Pediatric Hemato-Oncology Department, University Hospital La Paz, Institute for Health Research (IdiPAZ), Universidad Autónoma de Madrid, Madrid, Spain.
  • Panesso M; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Torrebadell M; CAR T-cell Unit. Leukemia and Lymphoma Department. Pediatric Cancer Center Barcelona (PCCB). Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain.
  • Delgado-Serrano J; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.
  • Pérez de Soto C; Pediatric Unit, Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.
  • Faura A; CAR T-cell Unit. Leukemia and Lymphoma Department. Pediatric Cancer Center Barcelona (PCCB). Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain.
  • González-Martínez B; Pediatric Hemato-Oncology Department, University Hospital La Paz, Institute for Health Research (IdiPAZ), Universidad Autónoma de Madrid, Madrid, Spain.
  • Castillo-Robleda A; Pediatric Hemato-Oncology Department, Peditric University Hospital del Niño Jesús, Madrid, Spain.
  • Diaz-de-Heredia C; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Pérez-Martínez A; Pediatric Hemato-Oncology Department, University Hospital La Paz, Institute for Health Research (IdiPAZ), Universidad Autónoma de Madrid, Madrid, Spain.
  • Pérez-Hurtado JM; Pediatric Unit, Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.
  • Rives S; Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Sant Joan de Déu, Leukemia and Pediatric Hematology Disorders, Developmental Tumors Biology Group, Barcelona, Spain.
  • Pérez-Simón JA; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red De Enfermedades Raras (CIBERER), Madrid, Spain.
Front Immunol ; 15: 1373852, 2024.
Article en En | MEDLINE | ID: mdl-38384474
ABSTRACT
[This corrects the article DOI 10.3389/fimmu.2023.1280580.].
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Front Immunol Año: 2024 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Front Immunol Año: 2024 Tipo del documento: Article País de afiliación: España